A first-ever collaboration between CDRD and Triumf could put Canada on the fast track for tackling late stage cancer.
Topic: nuclear medicine
Can science and business fruitfully cohabitate? It’s possible. And it’s happening in a Vancouver university campus where physicists can be found hard at work on their cyclotron particle accelerator in one room while industry people are in another room testing for radiation particles. These are common-day activities in TRIUMF, one of Canada’s large-scale research facilities, which is home to hundreds of researchers from academia, other research institutes and industry from across Canada and around the world.
TRIUMF is in the midst of a multi-year effort to establish an Institute for Advanced Medical Isotopes (IAMI), which would feature major infrastructure for creating and handling these radioactive products, as well as laboratories for testing them in scientific and clinical settings. While similar work takes place in a variety of university and hospital settings across the country, this facility is intended to concentrate all aspects of such work — from the creation of raw materials to clinical trial work of potential therapies — in a single location…